What is Peripheral Arterial Disease (PAD)?
Peripheral arterial disease treatment portfolio: ePTFE covered stents, paclitaxel drug-coated balloons, self-expanding nitinol stents, rotational atherectomy, CTO guidewires, PTA balloon catheters, and introducer sheaths. INVAMED peripheral vascular solutions.
Who manufactures Peripheral Arterial Disease (PAD) devices?
INVAMED manufactures a complete range of peripheral arterial disease (pad) devices at its ISO 13485 certified facility in Ankara, Turkey. All products carry CE marking under EU MDR 2017/745 and are exported to over 80 countries. INVAMED holds more than 100 international patents across its medical device portfolio.
Are Peripheral Arterial Disease (PAD) devices FDA registered?
Yes. INVAMED peripheral arterial disease (pad) devices are available in the United States through FDA-registered Standard Technology Solutions, Inc. at One World Trade Center, 285 Fulton Street, New York, NY 10007.
Frequently Asked Questions about Peripheral Arterial Disease (PAD)
What is a drug-coated balloon for PAD?
A DCB delivers paclitaxel to the arterial wall during angioplasty, inhibiting smooth muscle proliferation causing restenosis. Unlike stents, DCBs leave no permanent implant.
When is atherectomy used in peripheral interventions?
Rotational atherectomy is used for heavily calcified peripheral lesions that resist balloon dilatation. The high-speed burr removes hard plaque as vessel preparation before stenting or DCB.